The Potential of Public–Private Partnerships for the Bioeconomy

Abstract

Get full access to this article

View all access options for this article.

References

Schmidt Futures. Task Force on Synthetic Biology and the Bioeconomy. 2022. Available from: https://www.schmidtfutures.com/our-work/task-force-on-synthetic-biology-and-the-bioeconomy/ [Last accessed: May 24, 2023].

John

Cumbers

. Forbes. Eric Schmidt on Synthetic Biology, AI, Ethics And The Bioeconomy's ‘Seismic Shift’. 2023. Available from: https://www.forbes.com/sites/johncumbers/2023/05/13/eric-schmidt-on-synthetic-biology-ai-ethics-and-the-bioeconomys-seismic-shift/?ss=energy&sh=3efaa2955e11 [Last accessed: May 24, 2023].

Lee

, Vavitsas

. Driving innovation in biotechnology with Private-Public Partnerships: A Singapore perspective. Biotechnol Notes, 2021; 2:59–62; doi: 10.1016/j.biotno.2021.10.001

de Vrueh

RLA

, Crommelin

DJA

. Reflections on the future of pharmaceutical public-private partnerships: From input to impact. Pharm Res, 2017; 34:1985–1999. doi: 10.1007/s11095-017-2192-5

The World Bank. Government Objectives: Benefits and Risks of PPPs. 2022. Available from: https://ppp.worldbank.org/public-private-partnership/overview/ppp-objectives [Last accessed: May 24, 2023].